Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 146 articles:
HTML format

Single Articles

    July 2021
  1. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    PubMed     Abstract available

  2. ZHANG EB, Zhang X, Wang K, Zhang F, et al
    Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01934.
    PubMed     Abstract available

    June 2021
  3. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    PubMed     Abstract available

  4. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    PubMed     Abstract available

  5. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    PubMed     Abstract available

  6. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    PubMed     Abstract available

    May 2021
  7. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    PubMed     Abstract available

    April 2021
  8. CHEN S, Du Y, Xu B, Li Q, et al
    Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01780.
    PubMed     Abstract available

  9. CHEN K, Hou Y, Liao R, Li Y, et al
    LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01671.
    PubMed     Abstract available

    March 2021
  10. ZHANG G, Yang Y, Hu H, Liu K, et al
    Energy stress-induced linc01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01749.
    PubMed     Abstract available

  11. JING CY, Fu YP, Zhou C, Zhang MX, et al
    Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01705.
    PubMed     Abstract available

  12. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021 Mar 8. pii: 10.1038/s41388-021-01736.
    PubMed     Abstract available

  13. ALASADI A, Cao B, Guo J, Tao H, et al
    Mitochondrial uncoupler MB1-47 is efficacious in treating hepatic metastasis of pancreatic cancer in murine tumor transplantation models.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01688.
    PubMed     Abstract available

    January 2021
  14. LU Y, Li X, Liu H, Xue J, et al
    beta-Trcp and CK1delta-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01596.
    PubMed     Abstract available

    December 2020
  15. ZHANG Y, Yan Q, Gong L, Xu H, et al
    C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01593.
    PubMed     Abstract available

    November 2020
  16. YAO L, Xuan Y, Zhang H, Yang B, et al
    Reciprocal REGgamma-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
    Oncogene. 2020 Nov 23. pii: 10.1038/s41388-020-01558.
    PubMed     Abstract available

  17. YU J, Wang N, Gong Z, Liu L, et al
    Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma.
    Oncogene. 2020 Nov 12. pii: 10.1038/s41388-020-01545.
    PubMed     Abstract available

    October 2020
  18. LIU C, Zhou X, Long Q, Zeng H, et al
    Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01521.
    PubMed     Abstract available

  19. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available

  20. CHEN J, Xuan Z, Song W, Han W, et al
    EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation.
    Oncogene. 2020 Oct 24. pii: 10.1038/s41388-020-01522.
    PubMed     Abstract available

  21. VON FELDEN J, Craig AJ, Garcia-Lezana T, Labgaa I, et al
    Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
    Oncogene. 2020 Oct 23. pii: 10.1038/s41388-020-01519.
    PubMed     Abstract available

  22. GAMAEV L, Mizrahi L, Friehmann T, Rosenberg N, et al
    The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Oncogene. 2020 Oct 22. pii: 10.1038/s41388-020-01513.
    PubMed     Abstract available

  23. YAN Y, Huang P, Mao K, He C, et al
    Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01498.
    PubMed     Abstract available

  24. HE Q, Lin Z, Wang Z, Huang W, et al
    SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01500.
    PubMed     Abstract available

    September 2020
  25. SUN Z, Xue S, Zhang M, Xu H, et al
    Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01475.
    PubMed     Abstract available

  26. YANG B, Feng X, Liu H, Tong R, et al
    High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01450.
    PubMed     Abstract available

  27. ZHOU Q, Huang T, Jiang Z, Ge C, et al
    Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Oncogene. 2020 Sep 7. pii: 10.1038/s41388-020-01440.
    PubMed     Abstract available

    August 2020
  28. WU D, Wang Y, Yang G, Zhang S, et al
    A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.
    Oncogene. 2020 Aug 18. pii: 10.1038/s41388-020-01417.
    PubMed     Abstract available

  29. BARTOLOME RA, Pintado-Berninches L, Jaen M, de Los Rios V, et al
    SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Oncogene. 2020 Aug 15. pii: 10.1038/s41388-020-01419.
    PubMed     Abstract available

    July 2020
  30. SHI X, Liu TT, Yu XN, Balakrishnan A, et al
    microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Oncogene. 2020 Jul 27. pii: 10.1038/s41388-020-01401.
    PubMed     Abstract available

  31. FENG H, Liu J, Qiu Y, Liu Y, et al
    RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression.
    Oncogene. 2020 Jul 6. pii: 10.1038/s41388-020-1380.
    PubMed     Abstract available

    May 2020
  32. TSAI CN, Yu SC, Lee CW, Pang JS, et al
    SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.
    Oncogene. 2020 May 13. pii: 10.1038/s41388-020-1319.
    PubMed     Abstract available

  33. HUANG WJ, Tian XP, Bi SX, Zhang SR, et al
    The beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Oncogene. 2020 May 5. pii: 10.1038/s41388-020-1307.
    PubMed     Abstract available

  34. ZHANG C, Huang S, Zhuang H, Ruan S, et al
    YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1303.
    PubMed     Abstract available

  35. WILLIAMS M, Liu X, Zhang Y, Reske J, et al
    NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21(WAF1/CIP1) overexpression, which is reversed by metformin.
    Oncogene. 2020;39:3821-3836.
    PubMed     Abstract available

    April 2020
  36. TIAN L, Yao K, Liu K, Han B, et al
    PLK1/NF-kappaB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
    Oncogene. 2020;39:3145-3162.
    PubMed     Abstract available

    March 2020
  37. LI W, Dai Y, Shi B, Yue F, et al
    LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas.
    Oncogene. 2020 Mar 16. pii: 10.1038/s41388-020-1257.
    PubMed     Abstract available

  38. HUANG P, Xu Q, Yan Y, Lu Y, et al
    HBx/ERalpha complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
    Oncogene. 2020 Mar 10. pii: 10.1038/s41388-020-1254.
    PubMed     Abstract available

  39. PINATO DJ, Guerra N, Fessas P, Murphy R, et al
    Immune-based therapies for hepatocellular carcinoma.
    Oncogene. 2020 Mar 10. pii: 10.1038/s41388-020-1249.
    PubMed     Abstract available

  40. HSU BE, Roy J, Mouhanna J, Rayes RF, et al
    C3a elicits unique migratory responses in immature low-density neutrophils.
    Oncogene. 2020;39:2612-2623.
    PubMed     Abstract available

  41. XIAO Y, Liu G, Sun Y, Gao Y, et al
    Targeting the estrogen receptor alpha (ERalpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion.
    Oncogene. 2020;39:2493-2508.
    PubMed     Abstract available

  42. SAKSOUK N, Hajdari S, Perez Y, Pratlong M, et al
    The mouse HP1 proteins are essential for preventing liver tumorigenesis.
    Oncogene. 2020;39:2676-2691.
    PubMed     Abstract available

    February 2020
  43. ZHANG G, Tang X, Liang L, Zhang W, et al
    DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
    Oncogene. 2020 Feb 19. pii: 10.1038/s41388-020-1215.
    PubMed     Abstract available

  44. LUIKEN S, Fraas A, Bieg M, Sugiyanto R, et al
    NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.
    Oncogene. 2020 Feb 13. pii: 10.1038/s41388-020-1198.
    PubMed     Abstract available

  45. CHEN P, Duan X, Li X, Li J, et al
    HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1alpha.
    Oncogene. 2020 Feb 7. pii: 10.1038/s41388-020-1190.
    PubMed     Abstract available

  46. GUAN C, He L, Chang Z, Gu X, et al
    Correction: ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
    Oncogene. 2020 Feb 3. pii: 10.1038/s41388-020-1180.
    PubMed     Abstract available

  47. DAI K, Tanaka M, Kamiyoshi A, Sakurai T, et al
    Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.
    Oncogene. 2020;39:1914-1930.
    PubMed     Abstract available

    January 2020
  48. GU L, Zhu Y, Lin X, Tan X, et al
    Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1156.
    PubMed     Abstract available

  49. OUAHOUD S, Voorneveld PW, van der Burg LRA, de Jonge-Muller ESM, et al
    Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1157.
    PubMed     Abstract available

  50. GUAN YF, Huang QL, Ai YL, Chen QT, et al
    Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
    Oncogene. 2020 Jan 20. pii: 10.1038/s41388-020-1158.
    PubMed     Abstract available

    December 2019
  51. ZHOU Q, Huang T, Jiang Z, Ge C, et al
    Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1131.
    PubMed     Abstract available

    November 2019
  52. ZHONG R, Tian J, Fu M, Ma S, et al
    LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk.
    Oncogene. 2019 Nov 21. pii: 10.1038/s41388-019-1117.
    PubMed     Abstract available

  53. DONG KS, Chen Y, Yang G, Liao ZB, et al
    TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1107.
    PubMed     Abstract available

  54. THOMSEN MK, Skouboe MK, Boularan C, Vernejoul F, et al
    The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1108.
    PubMed     Abstract available

  55. ZHAO J, Hou Y, Yin C, Hu J, et al
    Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1093.
    PubMed     Abstract available

  56. ELIAS D, Vever H, Laenkholm AV, Gjerstorff MF, et al
    Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Nov 11. pii: 10.1038/s41388-019-1096.
    PubMed     Abstract available

  57. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Nov 7. pii: 10.1038/s41388-019-1095.
    PubMed     Abstract available

    October 2019
  58. XU G, Feng D, Yao Y, Li P, et al
    Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1072.
    PubMed     Abstract available

  59. GUAN C, He L, Chang Z, Gu X, et al
    ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1075.
    PubMed     Abstract available

  60. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Oct 11. pii: 10.1038/s41388-019-1052.
    PubMed     Abstract available

  61. LI B, Chen Y, Wang F, Guo J, et al
    Bmi1 drives hepatocarcinogenesis by repressing the TGFbeta2/SMAD signalling axis.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1043.
    PubMed     Abstract available

    September 2019
  62. LI X, Ding J, Wang X, Cheng Z, et al
    NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Oncogene. 2019 Sep 30. pii: 10.1038/s41388-019-1030.
    PubMed     Abstract available

  63. HSU YL, Huang MS, Hung JY, Chang WA, et al
    Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer.
    Oncogene. 2019 Sep 26. pii: 10.1038/s41388-019-1024.
    PubMed     Abstract available

    August 2019
  64. YUAN YM, Ma N, Zhang EB, Chen TW, et al
    BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0943.
    PubMed     Abstract available

  65. SHANKARAIAH RC, Callegari E, Guerriero P, Rimessi A, et al
    Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0942.
    PubMed     Abstract available

  66. WANG J, Li N, Huang ZB, Fu S, et al
    HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.
    Oncogene. 2019 Aug 7. pii: 10.1038/s41388-019-0907.
    PubMed     Abstract available

    July 2019
  67. CHU TH, Huang ST, Yang SF, Li CJ, et al
    Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.
    Oncogene. 2019 Jul 22. pii: 10.1038/s41388-019-0886.
    PubMed     Abstract available

  68. WEI T, Weiler SME, Toth M, Sticht C, et al
    YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells.
    Oncogene. 2019;38:5541-5550.
    PubMed     Abstract available

    June 2019
  69. BAO D, Zhao J, Zhou X, Yang Q, et al
    Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
    Oncogene. 2019;38:5007-5020.
    PubMed     Abstract available

    May 2019
  70. MARCHAND B, Pitarresi JR, Reichert M, Suzuki K, et al
    PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Oncogene. 2019;38:4325-4339.
    PubMed     Abstract available

    April 2019
  71. CUI Y, Wu X, Lin C, Zhang X, et al
    AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/beta-catenin/CBP signaling pathway.
    Oncogene. 2019 Apr 1. pii: 10.1038/s41388-019-0807.
    PubMed     Abstract available

    March 2019
  72. YANG H, Zhu R, Zhao X, Liu L, et al
    Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma.
    Oncogene. 2019 Mar 11. pii: 10.1038/s41388-019-0764.
    PubMed     Abstract available

  73. WANG Y, Xie BH, Lin WH, Huang YH, et al
    Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Oncogene. 2019 Mar 6. pii: 10.1038/s41388-019-0766.
    PubMed     Abstract available

    February 2019
  74. DANG S, Zhou J, Chen Y, Chen P, et al
    Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0759.
    PubMed     Abstract available

  75. TORRES-HERNANDEZ A, Wang W, Nikiforov Y, Tejada K, et al
    Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0734.
    PubMed     Abstract available

    January 2019
  76. FANG S, Liu M, Li L, Zhang FF, et al
    Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway.
    Oncogene. 2019 Jan 29. pii: 10.1038/s41388-019-0704.
    PubMed     Abstract available

  77. HUANG JF, Jiang HY, Cai H, Liu Y, et al
    Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0643.
    PubMed     Abstract available

  78. ZHAO X, Reebye V, Hitchen P, Fan J, et al
    Mechanisms involved in the activation of C/EBPalpha by small activating RNA in hepatocellular carcinoma.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0665.
    PubMed     Abstract available

  79. GUHA P, Gardell J, Darpolor J, Cunetta M, et al
    STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
    Oncogene. 2019;38:533-548.
    PubMed     Abstract available

  80. WANG LT, Wang SN, Chiou SS, Liu KY, et al
    TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer.
    Oncogene. 2019;38:518-532.
    PubMed     Abstract available

    December 2018
  81. CORTES E, Lachowski D, Rice A, Thorpe SD, et al
    Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor.
    Oncogene. 2018 Dec 21. pii: 10.1038/s41388-018-0631.
    PubMed     Abstract available

  82. LAOUIREM S, Sannier A, Norkowski E, Cauchy F, et al
    Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome.
    Oncogene. 2018 Dec 21. pii: 10.1038/s41388-018-0597.
    PubMed     Abstract available

  83. ZHANG H, Deng T, Ge S, Liu Y, et al
    Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0619.
    PubMed     Abstract available

  84. AHODANTIN J, Bou-Nader M, Cordier C, Megret J, et al
    Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0607.
    PubMed     Abstract available

    November 2018
  85. CHONG YC, Lim TE, Fu Y, Shin EM, et al
    Indian Hedgehog links obesity to development of hepatocellular carcinoma.
    Oncogene. 2018 Nov 23. pii: 10.1038/s41388-018-0585.
    PubMed     Abstract available

    October 2018
  86. WEN Y, Zhou X, Lu M, He M, et al
    Bclaf1 promotes angiogenesis by regulating HIF-1alpha transcription in hepatocellular carcinoma.
    Oncogene. 2018 Oct 26. pii: 10.1038/s41388-018-0552.
    PubMed     Abstract available

  87. DI LEO L, Vegliante R, Ciccarone F, Salvatori I, et al
    Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-alpha/p300-mediated acetylation of p53.
    Oncogene. 2018 Oct 26. pii: 10.1038/s41388-018-0545.
    PubMed     Abstract available

    September 2018
  88. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0505.
    PubMed     Abstract available

    August 2018
  89. HAN J, Wang F, Lan Y, Wang J, et al
    KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
    Oncogene. 2018 Aug 16. pii: 10.1038/s41388-018-0440.
    PubMed     Abstract available

  90. LAI CY, Liu H, Tin KX, Huang Y, et al
    Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Oncogene. 2018 Aug 10. pii: 10.1038/s41388-018-0442.
    PubMed     Abstract available

  91. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
    Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
    PubMed     Abstract available

  92. MENG J, Chen S, Lei YY, Han JX, et al
    Hsp90beta promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0428.
    PubMed     Abstract available

  93. YANG X, Qu S, Wang L, Zhang H, et al
    PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Oncogene. 2018 Aug 1. pii: 10.1038/s41388-018-0416.
    PubMed     Abstract available

  94. YOON S, Lee EJ, Choi JH, Chung T, et al
    Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.
    Oncogene. 2018;37:4443-4454.
    PubMed     Abstract available

    July 2018
  95. YANG Y, Wu XQ, Li WX, Huang HM, et al
    PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
    Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0383.
    PubMed     Abstract available

  96. VANIOTIS G, Rayes RF, Qi S, Milette S, et al
    Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis.
    Oncogene. 2018;37:3790-3805.
    PubMed     Abstract available

    June 2018
  97. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Abstract available

  98. REEBYE V, Huang KW, Lin V, Jarvis S, et al
    Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
    Oncogene. 2018;37:3216-3228.
    PubMed     Abstract available

  99. CHEN Z, Gao Y, Yao L, Liu Y, et al
    LncFZD6 initiates Wnt/beta-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Oncogene. 2018;37:3098-3112.
    PubMed     Abstract available

    May 2018
  100. LIU H, Chen W, Zhi X, Chen EJ, et al
    Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0309.
    PubMed     Abstract available

  101. TAN S, Li H, Zhang W, Shao Y, et al
    NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Oncogene. 2018 May 21. pii: 10.1038/s41388-018-0280.
    PubMed     Abstract available

  102. PINATO DJ
    Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0262.

  103. ZHAO Y, Hu X, Wei L, Song D, et al
    PARP10 suppresses tumor metastasis through regulation of Aurora A activity.
    Oncogene. 2018;37:2921-2935.
    PubMed     Abstract available

  104. JIANG Y, Xu E, Zhang J, Chen M, et al
    The Rbm38-p63 feedback loop is critical for tumor suppression and longevity.
    Oncogene. 2018;37:2863-2872.
    PubMed     Abstract available

  105. ZHANG H, Song Y, Yang H, Liu Z, et al
    Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-kappaB/IL-6/STAT3 axis.
    Oncogene. 2018;37:2456-2468.
    PubMed     Abstract available

    April 2018
  106. LABGAA I, Villacorta-Martin C, D'Avola D, Craig AJ, et al
    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0206.
    PubMed     Abstract available

    March 2018
  107. SU T, Liao J, Dai Z, Xu L, et al
    Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0169.
    PubMed     Abstract available

  108. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    PubMed     Abstract available

  109. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    PubMed     Abstract available

  110. EHEDEGO H, Mohs A, Jansen B, Hiththetiya K, et al
    Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0181.
    PubMed     Abstract available

  111. WANG J, Dong M, Xu Z, Song X, et al
    Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0188.
    PubMed     Abstract available

  112. DONG L, Yu L, Bai C, Liu L, et al
    USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
    Oncogene. 2018 Mar 2. pii: 10.1038/s41388-018-0137.
    PubMed     Abstract available

  113. IM JY, Kim BK, Lee JY, Park SH, et al
    DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
    Oncogene. 2018;37:1251-1262.
    PubMed     Abstract available

  114. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
    FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Oncogene. 2018;37:1192-1204.
    PubMed     Abstract available

    February 2018
  115. MA D, Chen X, Zhang PY, Zhang H, et al
    Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
    Oncogene. 2018;37:1041-1048.
    PubMed     Abstract available

  116. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
    Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
    Oncogene. 2018;37:627-637.
    PubMed     Abstract available

    January 2018
  117. HUA S, Lei L, Deng L, Weng X, et al
    miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0057.
    PubMed     Abstract available

  118. LIU MX, Jin L, Sun SJ, Liu P, et al
    Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0070.
    PubMed     Abstract available

  119. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    PubMed     Abstract available

    December 2017
  120. GUO P, Wang Y, Dai C, Tao C, et al
    Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0017.
    PubMed     Abstract available

  121. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
    Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
    PubMed     Abstract available

    November 2017
  122. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017;36:6747-6748.
    PubMed     Abstract available

  123. NAKATSUKA T, Tateishi K, Kudo Y, Yamamoto K, et al
    Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Oncogene. 2017;36:6262-6271.
    PubMed     Abstract available

    October 2017
  124. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Abstract available

  125. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Abstract available

  126. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Abstract available

  127. GUO P, Ma X, Zhao W, Huai W, et al
    TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    September 2017
  128. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  129. TRAN DDH, Kessler C, Niehus SE, Mahnkopf M, et al
    Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    August 2017
  130. FENG GX, Li J, Yang Z, Zhang SQ, et al
    Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  131. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Abstract available

  132. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Abstract available

  133. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  134. GOVAERE O, Petz M, Wouters J, Vandewynckel YP, et al
    The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  135. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Abstract available

    July 2017
  136. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  137. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    June 2017
  138. XIONG H, Ni Z, He J, Jiang S, et al
    LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Oncogene. 2017;36:3528-3540.
    PubMed     Abstract available

    May 2017
  139. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Abstract available

  140. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  141. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    March 2017
  142. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  143. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  144. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    February 2017
  145. BATTISTELLI C, Cicchini C, Santangelo L, Tramontano A, et al
    The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Oncogene. 2017;36:942-955.
    PubMed     Abstract available

    September 2016
  146. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.